NATURE’S SUNSHINE PRODUCTS, INC.

NATR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $6.1M
Depreciation & Amortization $4.5M
Depreciation
Amortization
Stock-Based Compensation $478.0K
Net Cash from Operating Activities $927.0K
Investing Activities
Capital Expenditures $3.2M
Business Acquisitions
Net Cash from Investing Activities $-297.0K
Financing Activities
Dividends Paid $776.0K
Stock Repurchases
Net Cash from Financing Activities $-776.0K
Net Change in Cash $685.0K
Free Cash Flow $-2.3M
← Newer Page 3 of 3 Older →